From: “Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report”
Case | Age (y.o.) | D-dimer (μg/ml) | FDP (μg/ml) | CA125 (U/ml) | hemoglobin (g/dl) | treatment for CI | treatment for adenomyosis | recurrence of CI | reference | |
---|---|---|---|---|---|---|---|---|---|---|
initial treatment | subsequent treatment | |||||||||
1 | 45 | 1.1 | – | 159 | 8.4 | hepalin | antipletelet therapy | GnRH agonist | – | Yamashiro K et al. 2012 |
2 | 44 | – | 5.9 | – | 7 | hepalin | warfalin | GnRH agonist | – | |
3 | 50 | 0.57 | – | 42.6 | 6.9 | aspirin | – | GnRH agonist | – | |
4 | 42 | 6.0 | – | 1750 | 8.6 | antiplatelet therapy | warfalin | GnRH agonist | + | |
5 | 59 | 7.0 | – | 334.8 | – | antithrombotic therapy | – | – | – | Hijikata N et al. 2016 |